These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 30393159)
1. Loss of TMEM126A promotes extracellular matrix remodeling, epithelial-to-mesenchymal transition, and breast cancer metastasis by regulating mitochondrial retrograde signaling. Sun HF; Yang XL; Zhao Y; Tian Q; Chen MT; Zhao YY; Jin W Cancer Lett; 2019 Jan; 440-441():189-201. PubMed ID: 30393159 [TBL] [Abstract][Full Text] [Related]
2. Novel mechanism for OSM-promoted extracellular matrix remodeling in breast cancer: LOXL2 upregulation and subsequent ECM alignment. Dinca SC; Greiner D; Weidenfeld K; Bond L; Barkan D; Jorcyk CL Breast Cancer Res; 2021 May; 23(1):56. PubMed ID: 34011405 [TBL] [Abstract][Full Text] [Related]
3. Extracellular Matrix Derived from High Metastatic Human Breast Cancer Triggers Epithelial-Mesenchymal Transition in Epithelial Breast Cancer Cells through αvβ3 Integrin. M Brandão-Costa R; Helal-Neto E; M Vieira A; Barcellos-de-Souza P; Morgado-Diaz J; Barja-Fidalgo C Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32340328 [TBL] [Abstract][Full Text] [Related]
4. Loss of RAB1B promotes triple-negative breast cancer metastasis by activating TGF-β/SMAD signaling. Jiang HL; Sun HF; Gao SP; Li LD; Hu X; Wu J; Jin W Oncotarget; 2015 Jun; 6(18):16352-65. PubMed ID: 25970785 [TBL] [Abstract][Full Text] [Related]
5. Elevated level of mitochondrial reactive oxygen species via fatty acid β-oxidation in cancer stem cells promotes cancer metastasis by inducing epithelial-mesenchymal transition. Wang C; Shao L; Pan C; Ye J; Ding Z; Wu J; Du Q; Ren Y; Zhu C Stem Cell Res Ther; 2019 Jun; 10(1):175. PubMed ID: 31196164 [TBL] [Abstract][Full Text] [Related]
6. Matrix Rigidity Controls Epithelial-Mesenchymal Plasticity and Tumor Metastasis via a Mechanoresponsive EPHA2/LYN Complex. Fattet L; Jung HY; Matsumoto MW; Aubol BE; Kumar A; Adams JA; Chen AC; Sah RL; Engler AJ; Pasquale EB; Yang J Dev Cell; 2020 Aug; 54(3):302-316.e7. PubMed ID: 32574556 [TBL] [Abstract][Full Text] [Related]
7. Downregulation of CFTR promotes epithelial-to-mesenchymal transition and is associated with poor prognosis of breast cancer. Zhang JT; Jiang XH; Xie C; Cheng H; Da Dong J; Wang Y; Fok KL; Zhang XH; Sun TT; Tsang LL; Chen H; Sun XJ; Chung YW; Cai ZM; Jiang WG; Chan HC Biochim Biophys Acta; 2013 Dec; 1833(12):2961-2969. PubMed ID: 23916755 [TBL] [Abstract][Full Text] [Related]
8. Suppression of motor protein KIF3C expression inhibits tumor growth and metastasis in breast cancer by inhibiting TGF-β signaling. Wang C; Wang C; Wei Z; Li Y; Wang W; Li X; Zhao J; Zhou X; Qu X; Xiang F Cancer Lett; 2015 Nov; 368(1):105-114. PubMed ID: 26272184 [TBL] [Abstract][Full Text] [Related]
9. RNF8 promotes epithelial-mesenchymal transition of breast cancer cells. Kuang J; Li L; Guo L; Su Y; Wang Y; Xu Y; Wang X; Meng S; Lei L; Xu L; Shao G J Exp Clin Cancer Res; 2016 Jun; 35(1):88. PubMed ID: 27259701 [TBL] [Abstract][Full Text] [Related]
10. MCUR1 facilitates epithelial-mesenchymal transition and metastasis via the mitochondrial calcium dependent ROS/Nrf2/Notch pathway in hepatocellular carcinoma. Jin M; Wang J; Ji X; Cao H; Zhu J; Chen Y; Yang J; Zhao Z; Ren T; Xing J J Exp Clin Cancer Res; 2019 Mar; 38(1):136. PubMed ID: 30909929 [TBL] [Abstract][Full Text] [Related]
11. A mitochondrial ROS pathway controls matrix metalloproteinase 9 levels and invasive properties in RAS-activated cancer cells. Mori K; Uchida T; Yoshie T; Mizote Y; Ishikawa F; Katsuyama M; Shibanuma M FEBS J; 2019 Feb; 286(3):459-478. PubMed ID: 30281903 [TBL] [Abstract][Full Text] [Related]
12. Extracellular matrix density promotes EMT by weakening cell-cell adhesions. Kumar S; Das A; Sen S Mol Biosyst; 2014 Apr; 10(4):838-50. PubMed ID: 24481128 [TBL] [Abstract][Full Text] [Related]
13. Glypican-3 induces a mesenchymal to epithelial transition in human breast cancer cells. Castillo LF; Tascón R; Lago Huvelle MR; Novack G; Llorens MC; Dos Santos AF; Shortrede J; Cabanillas AM; Bal de Kier Joffé E; Labriola L; Peters MG Oncotarget; 2016 Sep; 7(37):60133-60154. PubMed ID: 27507057 [TBL] [Abstract][Full Text] [Related]
14. VEGF/NRP-1axis promotes progression of breast cancer via enhancement of epithelial-mesenchymal transition and activation of NF-κB and β-catenin. Luo M; Hou L; Li J; Shao S; Huang S; Meng D; Liu L; Feng L; Xia P; Qin T; Zhao X Cancer Lett; 2016 Apr; 373(1):1-11. PubMed ID: 26805761 [TBL] [Abstract][Full Text] [Related]
15. ADAM12 induction by Twist1 promotes tumor invasion and metastasis via regulation of invadopodia and focal adhesions. Eckert MA; Santiago-Medina M; Lwin TM; Kim J; Courtneidge SA; Yang J J Cell Sci; 2017 Jun; 130(12):2036-2048. PubMed ID: 28468988 [TBL] [Abstract][Full Text] [Related]
16. MiR-373 drives the epithelial-to-mesenchymal transition and metastasis via the miR-373-TXNIP-HIF1α-TWIST signaling axis in breast cancer. Chen D; Dang BL; Huang JZ; Chen M; Wu D; Xu ML; Li R; Yan GR Oncotarget; 2015 Oct; 6(32):32701-12. PubMed ID: 26196741 [TBL] [Abstract][Full Text] [Related]
17. Sohlh2 suppresses epithelial to mesenchymal transition in breast cancer via downregulation of IL-8. Ji S; Zhang W; Zhang X; Hao C; Hao A; Gao Q; Zhang H; Sun J; Hao J Oncotarget; 2016 Aug; 7(31):49411-49424. PubMed ID: 27384482 [TBL] [Abstract][Full Text] [Related]
18. Leptin promotes epithelial-mesenchymal transition of breast cancer via the upregulation of pyruvate kinase M2. Wei L; Li K; Pang X; Guo B; Su M; Huang Y; Wang N; Ji F; Zhong C; Yang J; Zhang Z; Jiang Y; Liu Y; Chen T J Exp Clin Cancer Res; 2016 Oct; 35(1):166. PubMed ID: 27769315 [TBL] [Abstract][Full Text] [Related]
19. GP73 promotes epithelial-mesenchymal transition and invasion partly by activating TGF-β1/Smad2 signaling in hepatocellular carcinoma. Yang Y; Liu Q; Li Z; Zhang R; Jia C; Yang Z; Zhao H; Ya S; Mao R; Ailijiang T; Bao Y; Zhang H Carcinogenesis; 2018 Jul; 39(7):900-910. PubMed ID: 29365054 [TBL] [Abstract][Full Text] [Related]
20. Mesenchymal Transition of High-Grade Breast Carcinomas Depends on Extracellular Matrix Control of Myeloid Suppressor Cell Activity. Sangaletti S; Tripodo C; Santangelo A; Castioni N; Portararo P; Gulino A; Botti L; Parenza M; Cappetti B; Orlandi R; Tagliabue E; Chiodoni C; Colombo MP Cell Rep; 2016 Sep; 17(1):233-248. PubMed ID: 27681434 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]